Wenyi Xu

727 total citations
31 papers, 489 citations indexed

About

Wenyi Xu is a scholar working on Molecular Biology, Pharmacology and Surgery. According to data from OpenAlex, Wenyi Xu has authored 31 papers receiving a total of 489 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 6 papers in Pharmacology and 4 papers in Surgery. Recurrent topics in Wenyi Xu's work include Gut microbiota and health (7 papers), Ginseng Biological Effects and Applications (4 papers) and PI3K/AKT/mTOR signaling in cancer (4 papers). Wenyi Xu is often cited by papers focused on Gut microbiota and health (7 papers), Ginseng Biological Effects and Applications (4 papers) and PI3K/AKT/mTOR signaling in cancer (4 papers). Wenyi Xu collaborates with scholars based in China, United States and United Kingdom. Wenyi Xu's co-authors include Chongming Wu, Yanan Yang, Yongting Luo, Wei Cui, Guannan Li, Fengzhong Wang, Fengjiao Xin, Jiaqi Yu, Zhongsheng Yu and Fang Zhang and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and International Journal of Molecular Sciences.

In The Last Decade

Wenyi Xu

27 papers receiving 480 citations

Peers

Wenyi Xu

PHYSI

PHARM

EPIDE

SURGE

Liguo Chen China

Jixin Li China

Qiaoyun Wang China

Min Luo China

Imran Ali Sweden

Weifeng Huang China

Shujun Wei China

Duo Lv China

Qinglin Zha China

Liguo Chen China

Wenyi Xu

453 ×1.6

53 ×0.7

PHYSI

168 ×2.8

PHARM

77 ×1.6

EPIDE

49 ×1.4

SURGE

Citations per year, relative to Wenyi Xu Wenyi Xu (= 1×) peers Liguo Chen

Countries citing papers authored by Wenyi Xu

Since Specialization

Citations

This map shows the geographic impact of Wenyi Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenyi Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenyi Xu more than expected).

Fields of papers citing papers by Wenyi Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenyi Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenyi Xu. The network helps show where Wenyi Xu may publish in the future.

Co-authorship network of co-authors of Wenyi Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Wenyi Xu. A scholar is included among the top collaborators of Wenyi Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenyi Xu. Wenyi Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rosenberg, Benjamin M., et al.. (2025). Brain changes associated with depression treatment: a meta-analysis. NeuroImage Clinical. 48. 103874–103874.

Ding, Song, Wenyi Xu, Xueliang Liu, et al.. (2025). Curcumin-loaded nanoscale coordination polymers for ROS scavenging and anti-inflammatory therapy in atherosclerosis. Materials Today Bio. 34. 102152–102152.

Yang, Huachao, Wenyi Xu, Chenxuan Xu, et al.. (2025). A hybrid battery thermal management structure with partial embedding of finned liquid cooling plate into phase change material. Journal of Energy Storage. 134. 118254–118254.

Fu, Huiying, et al.. (2025). Impact of Rare-Earth Phosphate as a Hydrophilic Promoter on Boosting Electrooxidation of 5-Hydroxymethylfurfural: A DyPO₄/Ni₂P Example. ACS Applied Energy Materials. 8(7). 4824–4835. 1 indexed citations

Xu, Wenyi, et al.. (2024). Urolithin A Protects against Hypoxia-Induced Pulmonary Hypertension by Inhibiting Pulmonary Arterial Smooth Muscle Cell Pyroptosis via AMPK/NF-κB/NLRP3 Signaling. International Journal of Molecular Sciences. 25(15). 8246–8246. 8 indexed citations

Xu, Wenyi, et al.. (2024). Therapeutic potential of dietary nutrients and medicinal foods against metabolic disorders: Targeting Akkermansia muciniphila. SHILAP Revista de lepidopterología. 5(2). 329–349. 5 indexed citations

Yang, Yanan, Mingxi Li, Fang Zhang, et al.. (2024). Strain‐Level Screening of Human Gut Microbes Identifies Three Lactobacillus Strains as Next‐Generation Antidiabetic Probiotics. SHILAP Revista de lepidopterología. 6(2). 1041–1057. 2 indexed citations

Zhong, Shi, Yuqing Sun, Jinxi Huo, et al.. (2024). The gut microbiota‐aromatic hydrocarbon receptor (AhR) axis mediates the anticolitic effect of polyphenol‐rich extracts from Sanghuangporus. SHILAP Revista de lepidopterología. 3(2). e180–e180. 40 indexed citations

Xu, Wenyi, et al.. (2024). Advancing the reporting of pediatric EEG data: Tools for estimating reliability, effect size, and data quality metrics. Developmental Cognitive Neuroscience. 70. 101458–101458. 2 indexed citations

10.

Xu, Wenyi, Jiaqi Yu, Yanan Yang, et al.. (2023). Strain-level screening of human gut microbes identifies Blautia producta as a new anti-hyperlipidemic probiotic. Gut Microbes. 15(1). 2228045–2228045. 44 indexed citations

11.

Li, Zhenhao, Xiaofan Zhou, Wenyi Xu, et al.. (2022). Parabacteroides pekinense sp. nov.: a new bacterium isolated from the stool of a healthy man living in China. New Microbes and New Infections. 46. 100973–100973. 3 indexed citations

12.

Yang, Yanan, et al.. (2022). The berberine-enriched gut commensal Blautia producta ameliorates high-fat diet (HFD)-induced hyperlipidemia and stimulates liver LDLR expression. Biomedicine & Pharmacotherapy. 155. 113749–113749. 44 indexed citations

13.

Yang, Yanan, Shijie Cao, Wenyi Xu, et al.. (2022). Dual modulation of gut bacteria and fungi manifests the gut-based anti-hyperlipidemic effect of Coptidis Rhizoma. Biomedicine & Pharmacotherapy. 153. 113542–113542. 19 indexed citations

14.

Qian, Yuxuan, et al.. (2021). NR1D1 Deletion Induces Rupture‐Prone Vulnerable Plaques by Regulating Macrophage Pyroptosis via the NF‐κB/NLRP3 Inflammasome Pathway. Oxidative Medicine and Cellular Longevity. 2021(1). 5217572–5217572. 18 indexed citations

15.

An, Peng, Wenyi Xu, Junjie Luo, & Yongting Luo. (2021). Expanding TOR Complex 2 Signaling: Emerging Regulators and New Connections. Frontiers in Cell and Developmental Biology. 9. 713806–713806. 8 indexed citations

16.

Xu, Wenyi, et al.. (2021). Uric acid participating in female reproductive disorders: a review. Reproductive Biology and Endocrinology. 19(1). 65–65. 45 indexed citations

17.

Xu, Wenyi, et al.. (2020). Comprehensive Analysis of Differently Expressed and Methylated Genes in Preeclampsia. Computational and Mathematical Methods in Medicine. 2020. 1–10. 8 indexed citations

18.

Xu, Wenyi, Guannan Li, Zhengquan Yu, et al.. (2019). CD146 Regulates Growth Factor-Induced mTORC2 Activity Independent of the PI3K and mTORC1 Pathways. Cell Reports. 29(5). 1311–1322.e5. 18 indexed citations

19.

Luo, Yongting, Wenyi Xu, Guannan Li, & Wei Cui. (2018). Weighing In on mTOR Complex 2 Signaling: The Expanding Role in Cell Metabolism. Oxidative Medicine and Cellular Longevity. 2018(1). 7838647–7838647. 57 indexed citations

20.

Li, Shuying, et al.. (2016). Identification and Characterisation of a Novel Protein FIP-sch3 from Stachybotrys chartarum. PLoS ONE. 11(12). e0168436–e0168436. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact